Jerry McLaughlin is the founder of Life Biosciences. Life Biosciences has raised $80M in total funding. Latest round: Series D. Backed by Alpha Wave Ventures.
Jerry McLaughlin serves as the Chief Executive Officer of Life Biosciences, a clinical-stage biotechnology company. Life Biosciences focuses on developing cellular rejuvenation therapies to reverse and prevent diseases associated with aging, utilizing a proprietary Partial Epigenetic Reprogramming (PER) platform. The company recently secured an $80 million Series D financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library